Toxic hepatitis case with prolonged jaundice due to Favipiravir

Basit Öğe Kaydı
dc.contributor.authorYolacan, Ramazan
dc.contributor.authorKarabulut, Umit
dc.contributor.authorUzel, Ali
dc.contributor.authorUcmak, Feyzullah
dc.contributor.authorKaya, Muhsin
dc.date.accessioned2024-04-24T17:17:58Z
dc.date.available2024-04-24T17:17:58Z
dc.date.issued2022
dc.departmentDicle Üniversitesien_US
dc.description.abstractFavipiravir (FPV) is an antiviral drug used in the treatment of severe acute respiratory syndrome coronavirus 2 infection. The main side effects of this drug are teratogenicity and hyperuricemia. Limited information is available on other side effects. Here, we aimed to present our toxic hepatitis case with prolonged jaundice after FPV treatment.en_US
dc.identifier.doi10.14744/hf.2022.2022.0007
dc.identifier.endpage96en_US
dc.identifier.issn1307-5888
dc.identifier.issn2757-7392
dc.identifier.issue3en_US
dc.identifier.pmid36177102
dc.identifier.startpage95en_US
dc.identifier.trdizinid1173927
dc.identifier.urihttps://doi.org/10.14744/hf.2022.2022.0007
dc.identifier.urihttps://search.trdizin.gov.tr/yayin/detay/1173927
dc.identifier.urihttps://hdl.handle.net/11468/18490
dc.identifier.volume3en_US
dc.identifier.wosWOS:000863556400006
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakTR-Dizin
dc.indekslendigikaynakPubMed
dc.language.isoenen_US
dc.publisherKare Publen_US
dc.relation.ispartofHepatology Forum
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectCovid-19en_US
dc.subjectFavipiraviren_US
dc.subjectJaundiceen_US
dc.subjectToxic Hepatitisen_US
dc.titleToxic hepatitis case with prolonged jaundice due to Favipiraviren_US
dc.titleToxic hepatitis case with prolonged jaundice due to Favipiravir
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
TR-Dizin İndeksli Yayınlar Koleksiyonu